MedPath

A clinical study on the change of muscle strength, muscle mass, physical performances, and other parameters in perioperative esophageal cancer patients

Not Applicable
Conditions
esophageal cancer
Registration Number
JPRN-UMIN000038794
Lead Sponsor
agoya City University Graduate School of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients with the Performance Status on the Eastern Cooperative Oncology Group of 3 or greater (2) Patients with severe complications such as poorly-controlled diabetes, hypertension, etc. (3) Patients with muscular diseases including active myopathy or muscular dystrophy (4) Patients who have history of lower limb fractures within 6 months before the day of informed consent (5) Patients who cannot keep standing or sitting, walk, and etc. due to severe disabilities or diseases (e.g., stroke with hemiparesis, myasthenia gravis, Parkinson's disease, peripheral neuropathy, intermittent claudication due to advanced peripheral vascular disease with poorly-controlled pain, spinal stenosis, or severe osteoarthritis of the knee or hip, and others) (6) Patients who cannot continue deep breathing due to respiratory diseases (7) Patients with chronic obstructive pulmonary disease whose severity grade is 3 or greater on the modified medical research council dyspnea scale (The 5th JRS Guidelines for the Management of Chronic Obstructive Pulmonary Disease) (8) Pregnant and breastfeeding patients (9) Patients who are participated in a clinical trial or clinical study and received an unapproved drug within 16 weeks before the day of informed consent (10) Patients who are deemed unsuitable for inclusion in this study for any other reason based on assessment by the investigator or sub-investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
muscle strength, muscle mass, physical performances, respiratory functions, ADL, and body weight
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath